Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59
Open Access
- 1 March 1992
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 87 (3) , 415-421
- https://doi.org/10.1111/j.1365-2249.1992.tb03012.x
Abstract
CD59, the membrane regulator of aulologous C5b‐9 channel formation, exhibits variable sensitivity to cleavage by phosphatidylinositol‐specific phospholipase C (PI‐PLC), an enzyme that releases glyco‐inositolphospholipid (GPI)‐anchored proteins from cell surfaces. To determine whether the GPI‐anchor phospholipid of CD59 is similar to that of decay‐accelerating factor (DAF) and whether variation in its structure underlies its variable enzyme susceptibility, the GPI anchors of the two proteins expressed on erythrocytes, polymorphonuclear and mononuclear leucocytes were compared in situ and after purification. Flow cytometric analyses of PI‐PLC‐treated cells showed parallel cell type specific release of both proteins as a function of enzyme concentration. Non‐denaturing PAGE analyses of alkaline/hydroxylamine‐treated proteins (affinity‐purified from [125I]‐surface‐labelled cells) provided evidence for (i) comparable proportions of GPI‐anchor acylation, and (ii) alkali‐resistant rather than alkali‐sensitive lipid substituents in erythrocytes. These findings argue that the differential C5b‐9 sensitivity that distinguishes paroxysmal nocturnal haemoglobinuria II and III erythrocytes docs not derive from expression of CD59 molecules with alternative GPI‐anchor phospholipid structures.Keywords
This publication has 64 references indexed in Scilit:
- H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complementCellular Immunology, 1990
- Analysis of PI (phosphatidylinositol)‐anchoring antigens in a patient of paroxysmal nocturnal hemoglobinuria (PNH) reveals deficiency of 1F5 antigen (CD59), a new complement‐regulatory factorFEBS Letters, 1990
- Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20Biochemical and Biophysical Research Communications, 1989
- CELL-SURFACE ANCHORING OF PROTEINS VIA GLYCOSYL-PHOSPHATIDYLINOSITOL STRUCTURESAnnual Review of Biochemistry, 1988
- Demonstration of phosphatidylinositol anchors on Ly-6 molecules by specific phospholipase C digestion and gel electrophoresis in octylglucosideBiochemical and Biophysical Research Communications, 1987
- Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.Journal of Clinical Investigation, 1987
- Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipidBiochemistry, 1986
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Inhibition of complement by a substance isolated from human erythrocytes — I: Extraction from human erythrocyte stromataImmunochemistry, 1969